table of content
1 Introduction to Research & Analysis Reports
1.1 Induced Pluripotent Stem Cells (iPSCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Induced Pluripotent Stem Cells (iPSCs) Overall Market Size
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size: 2022 VS 2029
2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Induced Pluripotent Stem Cells (iPSCs) Players in Global Market
3.2 Top Global Induced Pluripotent Stem Cells (iPSCs) Companies Ranked by Revenue
3.3 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Companies
3.4 Top 3 and Top 5 Induced Pluripotent Stem Cells (iPSCs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Induced Pluripotent Stem Cells (iPSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Players in Global Market
3.6.1 List of Global Tier 1 Induced Pluripotent Stem Cells (iPSCs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Induced Pluripotent Stem Cells (iPSCs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Market Size Markets, 2022 & 2029
4.1.2 Human iPSCs
4.1.3 Mouse iPSCs
4.2 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
4.2.1 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
4.2.2 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
4.2.3 By Type - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Market Size, 2022 & 2029
5.1.2 Academic Research
5.1.3 Drug Development and Discovery
5.1.4 Toxicity Screening
5.1.5 Regenerative Medicine
5.1.6 Others
5.2 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
5.2.1 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
5.2.2 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
5.2.3 By Application - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Market Size, 2022 & 2029
6.2 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue & Forecasts
6.2.1 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2023
6.2.2 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue, 2024-2029
6.2.3 By Region - Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.3.2 US Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.3.3 Canada Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.3.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.4.2 Germany Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.3 France Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.4 U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.5 Italy Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.6 Russia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.7 Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.4.8 Benelux Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.5.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.4 South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.5 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.5.6 India Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.6.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.6.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue, 2018-2029
6.7.2 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.4 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
6.7.5 UAE Induced Pluripotent Stem Cells (iPSCs) Market Size, 2018-2029
7 Induced Pluripotent Stem Cells (iPSCs) Companies Profiles
7.1 Fujifilm Holding Corporation (CDI)
7.1.1 Fujifilm Holding Corporation (CDI) Company Summary
7.1.2 Fujifilm Holding Corporation (CDI) Business Overview
7.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.1.5 Fujifilm Holding Corporation (CDI) Key News & Latest Developments
7.2 Ncardia
7.2.1 Ncardia Company Summary
7.2.2 Ncardia Business Overview
7.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.2.5 Ncardia Key News & Latest Developments
7.3 Sumitomo Dainippon Pharma
7.3.1 Sumitomo Dainippon Pharma Company Summary
7.3.2 Sumitomo Dainippon Pharma Business Overview
7.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.3.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.4 Astellas Pharma Inc
7.4.1 Astellas Pharma Inc Company Summary
7.4.2 Astellas Pharma Inc Business Overview
7.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma Inc Key News & Latest Developments
7.5 Fate Therapeutics, Inc
7.5.1 Fate Therapeutics, Inc Company Summary
7.5.2 Fate Therapeutics, Inc Business Overview
7.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.5.5 Fate Therapeutics, Inc Key News & Latest Developments
7.6 Pluricell Biotech
7.6.1 Pluricell Biotech Company Summary
7.6.2 Pluricell Biotech Business Overview
7.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.6.5 Pluricell Biotech Key News & Latest Developments
7.7 Cell Inspire Biotechnology
7.7.1 Cell Inspire Biotechnology Company Summary
7.7.2 Cell Inspire Biotechnology Business Overview
7.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.7.5 Cell Inspire Biotechnology Key News & Latest Developments
7.8 ReproCELL
7.8.1 ReproCELL Company Summary
7.8.2 ReproCELL Business Overview
7.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Major Product Offerings
7.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue in Global Market (2018-2023)
7.8.5 ReproCELL Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
